Scleromyositis

WikiDoc Resources for Scleromyositis
Articles
Most recent articles on Scleromyositis Most cited articles on Scleromyositis Review articles on Scleromyositis Articles on Scleromyositis in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Scleromyositis Images of Scleromyositis Photos of Scleromyositis Podcasts & MP3s on Scleromyositis Videos on Scleromyositis
Evidence Based Medicine
Cochrane Collaboration on Scleromyositis Bandolier on Scleromyositis TRIP on Scleromyositis
Clinical Trials
Ongoing Trials on Scleromyositis at Clinical Trials.gov Trial results on Scleromyositis Clinical Trials on Scleromyositis at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Scleromyositis NICE Guidance on Scleromyositis NHS PRODIGY Guidance FDA on Scleromyositis CDC on Scleromyositis
Books
Books on Scleromyositis
News
Scleromyositis in the news Be alerted to news on Scleromyositis News trends on Scleromyositis
Commentary
Blogs on Scleromyositis
Definitions
Definitions of Scleromyositis
Patient Resources / Community
Patient resources on Scleromyositis Discussion groups on Scleromyositis Patient Handouts on Scleromyositis Directions to Hospitals Treating Scleromyositis Risk calculators and risk factors for Scleromyositis
Healthcare Provider Resources
Symptoms of Scleromyositis Causes & Risk Factors for Scleromyositis Diagnostic studies for Scleromyositis Treatment of Scleromyositis
Continuing Medical Education (CME)
CME Programs on Scleromyositis
International
Scleromyositis en Espanol Scleromyositis en Francais
Business
Scleromyositis in the Marketplace Patents on Scleromyositis
Experimental / Informatics
List of terms related to Scleromyositis

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Scleromyositis or the PM/Scl overlap syndrome is an autoimmune disease in which the immune system attacks the body. Patients with scleromyositis have symptoms of both systemic scleroderma and either polymyositis or dermatomyositis, and is therefore considered an overlap syndrome. Although it is a rare disease, it is one of the more common overlap syndromes seen in scleroderma patients, together with MCTD and synthetase syndrome. Autoantibodies often found in these patients are the anti-PM/Scl (anti-exosome) antibodies.

The symptoms that are seen most often are typical symptoms of the individual autoimmune diseases and include Raynaud's phenomenon, arthritis, myositis and scleroderma. Treatment of these patients is therefore strongly dependant on the exact symptoms with which a patient reports to a physician and is similar to treatment for the individual autoimmune disease, often involving either immunosuppressive or immunomodulating drugs.